United States Biotechnology & Medical Research

Veracyte, Inc. (VCYT)

Track

Track

Veracyte, Inc. experienced fifteen insider trading transactions over the past ninety days, all involving sales totaling approximately 2.85 million dollars. Key executives, including the CFO and Chief Scientific Officer, offloaded shares through planned or proposed divestments. This activity follows a recent earnings report beat and occurs amid a 22.6% decline in stock price.
Ticker: VCYT Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Veracyte, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.0
Bhanji Muna Non-Executive Director
Transaction date
Planned sale
Price
485.31
Quantity 32,852 -3.1%
Value US$510,432
1.5
JENS HOLSTEIN Director Non-Executive Director
Transaction date
Proposed sale
Price
182.07
Quantity 60,385
Value US$1,910,063
3.2
Leite John Global Chief Commercial Off Officer
Transaction date
Planned sale
Price
363.93
Quantity 83,986 +29.7%
Value US$2,239,742
3.2
JOHN LEITE Officer Officer
Transaction date
Proposed sale
Price
39.80
Quantity 4,015
Value US$159,777
1.5
Holstein Jens Non-Executive Director
Transaction date
Planned sale
Price
40.95
Quantity 5,000 -15.4%
Value US$204,747
1.5
JENS HOLSTEIN Director Non-Executive Director
Transaction date
Proposed sale
Price
40.95
Quantity 5,000
Value US$204,747
McGuire Annie EVP, General Counsel Officer
Transaction date
Planned sale
Price
43.67
Quantity 1,100 -0.8%
Value US$48,039
McGuire Annie EVP, General Counsel Officer
Transaction date
Planned sale
Price
42.79
Quantity 2,154 -1.6%
Value US$92,173
Febbo Phillip G. Chief Scientific & Med Officer Officer
Transaction date
Planned sale
Price
43.66
Quantity 2,705 -2.0%
Value US$118,105
Febbo Phillip G. Chief Scientific & Med Officer Officer
Transaction date
Planned sale
Price
42.89
Quantity 10,405 -7.1%
Value US$446,305
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
43.71
Quantity 1,175 -0.7%
Value US$51,364
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
42.81
Quantity 2,477 -1.5%
Value US$106,030
0.7
REBECCA CHAMBERS Officer Officer
Transaction date
Proposed sale
Price
44.67
Quantity 3,652
Value US$163,135
PHILLIP FEBBO Officer Officer
Transaction date
Proposed sale
Price
44.67
Quantity 13,110
Value US$585,624
2.0
Bhanji Muna Non-Executive Director
Transaction date
Planned sale
Price
42.97
Quantity 1,864 -4.2%
Value US$80,096
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
53.55
Quantity 529 -3.4%
Value US$28,328
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
52.78
Quantity 3,200 -17.0%
Value US$168,906
KARIN EASTHAM Director Non-Executive Director
Transaction date
Proposed sale
Price
51.29
Quantity 3,729
Value US$191,260
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
50.12
Quantity 138,051 -23.9%
Value US$6,919,585
3.2
Leite John Global Chief Commercial Off Officer
Transaction date
Planned sale
Price
50.07
Quantity 13,975 -9.6%
Value US$699,732
McGuire Annie EVP, General Counsel Officer
Transaction date
Planned sale
Price
50.12
Quantity 1,776 -1.3%
Value US$89,007
McGuire Annie EVP, General Counsel Officer
Transaction date
Planned sale
Price
49.31
Quantity 1,400 -1.0%
Value US$69,029
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
50.09
Quantity 1,961 -1.1%
Value US$98,229
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
49.28
Quantity 1,600 -0.9%
Value US$78,854
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
48.69
Quantity 3,176
Value US$154,639
3.2
John Leite Officer Officer
Transaction date
Proposed sale
Price
48.69
Quantity 13,975
Value US$680,443
2.6
MARC STAPLEY Director; Officer Executive Director
Transaction date
Proposed sale
Price
48.69
Quantity 138,051
Value US$6,721,703
0.7
REBECCA CHAMBERS Officer Officer
Transaction date
Proposed sale
Price
48.69
Quantity 3,561
Value US$173,385
3.2
Wygant Jonathan VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
45.40
Quantity 24,000 -34.6%
Value US$1,089,624
EPSTEIN ROBERT S Non-Executive Director
Transaction date
Planned sale
Price
44.01
Quantity 10,000 -16.0%
Value US$440,129
ROBERT EPSTEIN Director Non-Executive Director
Transaction date
Proposed sale
Price
41.69
Quantity 10,000
Value US$416,900
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
40.00
Quantity 5,102 -3.4%
Value US$204,080
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
38.05
Quantity 5,102 -3.3%
Value US$194,131
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
32.97
Quantity 10,204
Value US$336,426
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
36.34
Quantity 1,664 -1.7%
Value US$60,469
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
35.29
Quantity 4,994 -4.9%
Value US$176,256
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
36.28
Quantity 26,279 -6.8%
Value US$953,368
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
35.56
Quantity 19,244 -4.8%
Value US$684,226
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
36.33
Quantity 13,941 -9.6%
Value US$506,460
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
35.55
Quantity 4,400 -2.9%
Value US$156,409
3.2
Leite John Chief Commercial Officer-CLIA Officer
Transaction date
Planned sale
Price
35.19
Quantity 5,260 -4.7%
Value US$185,083
3.2
John Leite Officer Officer
Transaction date
Proposed sale
Price
35.08
Quantity 5,260
Value US$184,521
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
35.08
Quantity 6,658
Value US$233,563
0.7
REBECCA CHAMBERS Officer Officer
Transaction date
Proposed sale
Price
35.08
Quantity 18,341
Value US$643,402
2.6
MARC STAPLEY Director; Officer Executive Director
Transaction date
Proposed sale
Price
35.08
Quantity 45,523
Value US$1,596,947
Febbo Phillip G. Chief Scientific & Med Officer Officer
Transaction date
Planned sale
Price
36.16
Quantity 13,425 -10.3%
Value US$485,429
PHILLIP FEBBO Officer Officer
Transaction date
Proposed sale
Price
36.59
Quantity 13,425
Value US$491,221
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
43.68
Quantity 100 -0.1%
Value US$4,368
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
43.13
Quantity 10,639 -13.6%
Value US$458,836
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
43.53
Quantity 10,739
Value US$467,469
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
46.59
Quantity 800 -5.6%
Value US$37,272
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
45.84
Quantity 12,808 -47.2%
Value US$587,080
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
44.52
Quantity 6,392 -19.0%
Value US$284,571
KARIN EASTHAM Director Non-Executive Director
Transaction date
Proposed sale
Price
47.41
Quantity 20,000
Value US$948,200
ANN MCGUIRE Officer Officer
Transaction date
Proposed sale
Price
47.75
Quantity 1,422
Value US$67,900
0.7
REBECCA CHAMBERS Officer Officer
Transaction date
Proposed sale
Price
47.75
Quantity 13,278
Value US$634,024
2.6
MARC STAPLEY Director; Officer Executive Director
Transaction date
Proposed sale
Price
47.75
Quantity 7,668
Value US$366,147
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
47.51
Quantity 702 -0.9%
Value US$33,352
McGuire Annie SVP, General Counsel Officer
Transaction date
Planned sale
Price
47.10
Quantity 720 -0.9%
Value US$33,909
3.2
Leite John Chief Commercial Officer-CLIA Officer
Transaction date
Planned sale
Price
47.51
Quantity 1,278 -1.5%
Value US$60,718
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
47.25
Quantity 4,741 -4.2%
Value US$224,009
0.7
Chambers Rebecca Chief Financial Officer Officer
Transaction date
Planned sale
Price
46.61
Quantity 8,537 -7.0%
Value US$397,946
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
47.35
Quantity 3,220 -1.0%
Value US$152,462
2.6
Stapley Marc Chief Executive Officer Executive Director
Transaction date
Planned sale
Price
46.90
Quantity 4,448 -1.4%
Value US$208,613
3.2
Leite John Chief Commercial Officer-CLIA Officer
Transaction date
Planned sale
Price
50.00
Quantity 2,808 -3.2%
Value US$140,400
1.6
JONES EVAN/ FA Non-Executive Director
Transaction date
Planned sale
Price
50.25
Quantity 1,106 -3.6%
Value US$55,576
1.6
Evan Jones Director Non-Executive Director
Transaction date
Proposed sale
Price
49.38
Quantity 5,000
Value US$246,900
3.2
John Leite Officer Officer
Transaction date
Proposed sale
Price
46.70
Quantity 4,086
Value US$190,816
1.5
Holstein Jens Non-Executive Director
Transaction date
Planned sale
Price
43.21
Quantity 1,460 -5.1%
Value US$63,086
1.5
Holstein Jens Non-Executive Director
Transaction date
Planned sale
Price
42.48
Quantity 7,049 -19.7%
Value US$299,417
1.5
Holstein Jens Non-Executive Director
Transaction date
Planned sale
Price
40.95
Quantity 1,491 -4.0%
Value US$61,060
1.5
JENS HOLSTEIN Director Non-Executive Director
Transaction date
Proposed sale
Price
42.36
Quantity 10,000
Value US$423,563
3.2
Wygant Jonathan VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
42.33
Quantity 5,102 -11.6%
Value US$215,978
3.2
Wygant Jonathan VP, Chief Accounting Officer Officer
Transaction date
Sale
Price
40.21
Quantity 5,818 -11.7%
Value US$233,929
EASTHAM KARIN Non-Executive Director
Transaction date
Planned sale
Price
40.02
Quantity 9,674 -41.6%
Value US$387,191
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-10-20 2026-10-19 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
32,852 -3.1%
485.31
US$510,432 		32,852 -3.1% 485.31 US$510,432
2026-09-24 2026-09-24 PrS Proposed sale
1.5
JENS HOLSTEIN

Director

Non-Executive Director
60,385
182.07
US$1,910,063 		60,385 182.07 US$1,910,063
2026-09-22 2026-09-21 PlS Planned sale
3.2
Leite John

Global Chief Commercial Off

Officer
83,986 +29.7%
363.93
US$2,239,742 		83,986 +29.7% 363.93 US$2,239,742
2026-09-21 2026-09-21 PrS Proposed sale
3.2
JOHN LEITE

Officer

Officer
4,015
39.80
US$159,777 		4,015 39.80 US$159,777
2026-09-16 2026-09-14 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
5,000 -15.4%
40.95
US$204,747 		5,000 -15.4% 40.95 US$204,747
2026-09-14 2026-09-14 PrS Proposed sale
1.5
JENS HOLSTEIN

Director

Non-Executive Director
5,000
40.95
US$204,747 		5,000 40.95 US$204,747
2026-09-04 2026-09-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
1,100 -0.8%
43.67
US$48,039 		1,100 -0.8% 43.67 US$48,039
2026-09-04 2026-09-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
2,154 -1.6%
42.79
US$92,173 		2,154 -1.6% 42.79 US$92,173
2026-09-04 2026-09-04 PlS Planned sale
Febbo Phillip G.

Chief Scientific & Med Officer

Officer
2,705 -2.0%
43.66
US$118,105 		2,705 -2.0% 43.66 US$118,105
2026-09-04 2026-09-04 PlS Planned sale
Febbo Phillip G.

Chief Scientific & Med Officer

Officer
10,405 -7.1%
42.89
US$446,305 		10,405 -7.1% 42.89 US$446,305
2026-09-04 2026-09-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,175 -0.7%
43.71
US$51,364 		1,175 -0.7% 43.71 US$51,364
2026-09-04 2026-09-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
2,477 -1.5%
42.81
US$106,030 		2,477 -1.5% 42.81 US$106,030
2026-09-04 2026-09-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
3,652
44.67
US$163,135 		3,652 44.67 US$163,135
2026-09-04 2026-09-04 PrS Proposed sale
PHILLIP FEBBO

Officer

Officer
13,110
44.67
US$585,624 		13,110 44.67 US$585,624
2026-09-03 2026-09-01 PlS Planned sale
2.0
Bhanji Muna
Non-Executive Director
1,864 -4.2%
42.97
US$80,096 		1,864 -4.2% 42.97 US$80,096
2026-06-22 2026-06-18 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
529 -3.4%
53.55
US$28,328 		529 -3.4% 53.55 US$28,328
2026-06-22 2026-06-18 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
3,200 -17.0%
52.78
US$168,906 		3,200 -17.0% 52.78 US$168,906
2026-06-18 2026-06-18 PrS Proposed sale
KARIN EASTHAM

Director

Non-Executive Director
3,729
51.29
US$191,260 		3,729 51.29 US$191,260
2026-06-04 2026-06-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
138,051 -23.9%
50.12
US$6,919,585 		138,051 -23.9% 50.12 US$6,919,585
2026-06-04 2026-06-04 PlS Planned sale
3.2
Leite John

Global Chief Commercial Off

Officer
13,975 -9.6%
50.07
US$699,732 		13,975 -9.6% 50.07 US$699,732
2026-06-04 2026-06-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
1,776 -1.3%
50.12
US$89,007 		1,776 -1.3% 50.12 US$89,007
2026-06-04 2026-06-04 PlS Planned sale
McGuire Annie

EVP, General Counsel

Officer
1,400 -1.0%
49.31
US$69,029 		1,400 -1.0% 49.31 US$69,029
2026-06-04 2026-06-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,961 -1.1%
50.09
US$98,229 		1,961 -1.1% 50.09 US$98,229
2026-06-04 2026-06-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
1,600 -0.9%
49.28
US$78,854 		1,600 -0.9% 49.28 US$78,854
2026-06-04 2026-06-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
3,176
48.69
US$154,639 		3,176 48.69 US$154,639
2026-06-04 2026-06-04 PrS Proposed sale
3.2
John Leite

Officer

Officer
13,975
48.69
US$680,443 		13,975 48.69 US$680,443
2026-06-04 2026-06-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
138,051
48.69
US$6,721,703 		138,051 48.69 US$6,721,703
2026-06-04 2026-06-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
3,561
48.69
US$173,385 		3,561 48.69 US$173,385
2026-05-27 2026-05-22 S Sale
3.2
Wygant Jonathan

VP, Chief Accounting Officer

Officer
24,000 -34.6%
45.40
US$1,089,624 		24,000 -34.6% 45.40 US$1,089,624
2026-05-22 2026-05-20 PlS Planned sale
EPSTEIN ROBERT S
Non-Executive Director
10,000 -16.0%
44.01
US$440,129 		10,000 -16.0% 44.01 US$440,129
2026-05-20 2026-05-20 PrS Proposed sale
ROBERT EPSTEIN

Director

Non-Executive Director
10,000
41.69
US$416,900 		10,000 41.69 US$416,900
2026-05-08 2026-05-06 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
5,102 -3.4%
40.00
US$204,080 		5,102 -3.4% 40.00 US$204,080
2026-05-08 2026-05-06 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
5,102 -3.3%
38.05
US$194,131 		5,102 -3.3% 38.05 US$194,131
2026-05-06 2026-05-06 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
10,204
32.97
US$336,426 		10,204 32.97 US$336,426
2026-03-06 2026-03-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
1,664 -1.7%
36.34
US$60,469 		1,664 -1.7% 36.34 US$60,469
2026-03-06 2026-03-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
4,994 -4.9%
35.29
US$176,256 		4,994 -4.9% 35.29 US$176,256
2026-03-06 2026-03-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
26,279 -6.8%
36.28
US$953,368 		26,279 -6.8% 36.28 US$953,368
2026-03-06 2026-03-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
19,244 -4.8%
35.56
US$684,226 		19,244 -4.8% 35.56 US$684,226
2026-03-06 2026-03-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
13,941 -9.6%
36.33
US$506,460 		13,941 -9.6% 36.33 US$506,460
2026-03-06 2026-03-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
4,400 -2.9%
35.55
US$156,409 		4,400 -2.9% 35.55 US$156,409
2026-03-06 2026-03-04 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
5,260 -4.7%
35.19
US$185,083 		5,260 -4.7% 35.19 US$185,083
2026-03-04 2026-03-04 PrS Proposed sale
3.2
John Leite

Officer

Officer
5,260
35.08
US$184,521 		5,260 35.08 US$184,521
2026-03-04 2026-03-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
6,658
35.08
US$233,563 		6,658 35.08 US$233,563
2026-03-04 2026-03-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
18,341
35.08
US$643,402 		18,341 35.08 US$643,402
2026-03-04 2026-03-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
45,523
35.08
US$1,596,947 		45,523 35.08 US$1,596,947
2026-03-04 2026-03-02 PlS Planned sale
Febbo Phillip G.

Chief Scientific & Med Officer

Officer
13,425 -10.3%
36.16
US$485,429 		13,425 -10.3% 36.16 US$485,429
2026-03-02 2026-03-02 PrS Proposed sale
PHILLIP FEBBO

Officer

Officer
13,425
36.59
US$491,221 		13,425 36.59 US$491,221
2025-12-17 2025-12-16 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
100 -0.1%
43.68
US$4,368 		100 -0.1% 43.68 US$4,368
2025-12-17 2025-12-16 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
10,639 -13.6%
43.13
US$458,836 		10,639 -13.6% 43.13 US$458,836
2025-12-16 2025-12-16 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
10,739
43.53
US$467,469 		10,739 43.53 US$467,469
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
800 -5.6%
46.59
US$37,272 		800 -5.6% 46.59 US$37,272
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
12,808 -47.2%
45.84
US$587,080 		12,808 -47.2% 45.84 US$587,080
2025-12-08 2025-12-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
6,392 -19.0%
44.52
US$284,571 		6,392 -19.0% 44.52 US$284,571
2025-12-05 2025-12-05 PrS Proposed sale
KARIN EASTHAM

Director

Non-Executive Director
20,000
47.41
US$948,200 		20,000 47.41 US$948,200
2025-12-04 2025-12-04 PrS Proposed sale
ANN MCGUIRE

Officer

Officer
1,422
47.75
US$67,900 		1,422 47.75 US$67,900
2025-12-04 2025-12-04 PrS Proposed sale
0.7
REBECCA CHAMBERS

Officer

Officer
13,278
47.75
US$634,024 		13,278 47.75 US$634,024
2025-12-04 2025-12-04 PrS Proposed sale
2.6
MARC STAPLEY

Director; Officer

Executive Director
7,668
47.75
US$366,147 		7,668 47.75 US$366,147
2025-12-04 2025-12-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
702 -0.9%
47.51
US$33,352 		702 -0.9% 47.51 US$33,352
2025-12-04 2025-12-04 PlS Planned sale
McGuire Annie

SVP, General Counsel

Officer
720 -0.9%
47.10
US$33,909 		720 -0.9% 47.10 US$33,909
2025-12-04 2025-12-04 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
1,278 -1.5%
47.51
US$60,718 		1,278 -1.5% 47.51 US$60,718
2025-12-04 2025-12-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
4,741 -4.2%
47.25
US$224,009 		4,741 -4.2% 47.25 US$224,009
2025-12-04 2025-12-04 PlS Planned sale
0.7
Chambers Rebecca

Chief Financial Officer

Officer
8,537 -7.0%
46.61
US$397,946 		8,537 -7.0% 46.61 US$397,946
2025-12-04 2025-12-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
3,220 -1.0%
47.35
US$152,462 		3,220 -1.0% 47.35 US$152,462
2025-12-04 2025-12-04 PlS Planned sale
2.6
Stapley Marc

Chief Executive Officer

Executive Director
4,448 -1.4%
46.90
US$208,613 		4,448 -1.4% 46.90 US$208,613
2025-11-26 2025-11-25 PlS Planned sale
3.2
Leite John

Chief Commercial Officer-CLIA

Officer
2,808 -3.2%
50.00
US$140,400 		2,808 -3.2% 50.00 US$140,400
2025-11-26 2025-11-25 PlS Planned sale
1.6
JONES EVAN/ FA
Non-Executive Director
1,106 -3.6%
50.25
US$55,576 		1,106 -3.6% 50.25 US$55,576
2025-11-25 2025-11-25 PrS Proposed sale
1.6
Evan Jones

Director

Non-Executive Director
5,000
49.38
US$246,900 		5,000 49.38 US$246,900
2025-11-25 2025-11-25 PrS Proposed sale
3.2
John Leite

Officer

Officer
4,086
46.70
US$190,816 		4,086 46.70 US$190,816
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
1,460 -5.1%
43.21
US$63,086 		1,460 -5.1% 43.21 US$63,086
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
7,049 -19.7%
42.48
US$299,417 		7,049 -19.7% 42.48 US$299,417
2025-11-21 2025-11-20 PlS Planned sale
1.5
Holstein Jens
Non-Executive Director
1,491 -4.0%
40.95
US$61,060 		1,491 -4.0% 40.95 US$61,060
2025-11-20 2025-11-20 PrS Proposed sale
1.5
JENS HOLSTEIN

Director

Non-Executive Director
10,000
42.36
US$423,563 		10,000 42.36 US$423,563
2025-11-12 2025-11-10 S Sale
3.2
Wygant Jonathan

VP, Chief Accounting Officer

Officer
5,102 -11.6%
42.33
US$215,978 		5,102 -11.6% 42.33 US$215,978
2025-11-12 2025-11-07 S Sale
3.2
Wygant Jonathan

VP, Chief Accounting Officer

Officer
5,818 -11.7%
40.21
US$233,929 		5,818 -11.7% 40.21 US$233,929
2025-11-07 2025-11-05 PlS Planned sale
EASTHAM KARIN
Non-Executive Director
9,674 -41.6%
40.02
US$387,191 		9,674 -41.6% 40.02 US$387,191
Explore more

More insider trading research around Veracyte, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America